{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T06:18:47Z","timestamp":1793945927615,"version":"4.8.0"},"reference-count":166,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004331","name":"Johnson and Johnson","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004331","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004328","name":"Genentech","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004328","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacr.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Radiology"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.jacr.2021.02.013","type":"journal-article","created":{"date-parts":[[2021,5,3]],"date-time":"2021-05-03T04:03:28Z","timestamp":1620014608000},"page":"S153-S173","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"S","title":["ACR Appropriateness Criteria\u00ae Radiologic Management of Portal Hypertension"],"prefix":"10.1016","volume":"18","author":[{"given":"Jason W.","family":"Pinchot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjeeva P.","family":"Kalva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bill S.","family":"Majdalany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles Y.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osmanuddin","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumeet K.","family":"Asrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brooks D.","family":"Cash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Eldrup-Jorgensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Tuba","family":"Kendi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Scheidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Sella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin E.","family":"Dill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric J.","family":"Hohenwalter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.jacr.2021.02.013_bib1","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.1016\/j.jhep.2008.01.021","article-title":"The management of portal hypertension: rational basis, available treatments and future options","volume":"48","author":"Bosch","year":"2008","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jacr.2021.02.013_bib2","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.3748\/wjg.v18.i11.1166","article-title":"Treatment of portal hypertension","volume":"18","author":"Bari","year":"2012","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jacr.2021.02.013_bib3","doi-asserted-by":"crossref","first-page":"S239","DOI":"10.1016\/j.jacr.2020.01.017","article-title":"ACR Appropriateness Criteria\u00ae Radiologic Management of Gastric Varices","volume":"17","author":"Kim","year":"2020","journal-title":"J\u00a0Am Coll Radiol"},{"key":"10.1016\/j.jacr.2021.02.013_bib4","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1053\/j.gastro.2015.01.032","article-title":"Decreasing mortality among patients hospitalized with cirrhosis in the United States from 2002 through 2010","volume":"148","author":"Schmidt","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jacr.2021.02.013_bib5","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/hep.1840070124","article-title":"Compensated cirrhosis: natural history and prognostic factors","volume":"7","author":"Gines","year":"1987","journal-title":"Hepatology"},{"key":"10.1016\/j.jacr.2021.02.013_bib6","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jhep.2005.10.013","article-title":"Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies","volume":"44","author":"D\u2019Amico","year":"2006","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jacr.2021.02.013_bib7","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.cgh.2006.08.007","article-title":"Natural history of patients hospitalized for management of cirrhotic ascites","volume":"4","author":"Planas","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jacr.2021.02.013_bib8","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0950-3528(97)90038-5","article-title":"Natural history. Clinical-haemodynamic correlations. Prediction of the risk of bleeding","volume":"11","author":"D\u2019Amico","year":"1997","journal-title":"Baillieres Clin Gastroenterol"},{"key":"10.1016\/j.jacr.2021.02.013_bib9","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1055\/s-2007-1007362","article-title":"Refractory ascites","volume":"13","author":"Runyon","year":"1993","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jacr.2021.02.013_bib10","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1111\/j.1572-0241.2003.08664.x","article-title":"Transjugular intrahepatic portosystemic shunt for refractory ascites: an analysis of the literature on efficacy, morbidity, and mortality","volume":"98","author":"Russo","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jacr.2021.02.013_bib11","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/S0140-6736(03)14903-3","article-title":"Hepatorenal syndrome","volume":"362","author":"Gines","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.jacr.2021.02.013_bib12","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1056\/NEJMra0809139","article-title":"Renal failure in cirrhosis","volume":"361","author":"Gines","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacr.2021.02.013_bib13","first-page":"1310","article-title":"Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis","volume":"56","author":"Salerno","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.jacr.2021.02.013_bib14","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1136\/gut.2006.107789","article-title":"Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis","volume":"84","author":"Salerno","year":"2008","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.jacr.2021.02.013_bib15","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jhep.2007.10.008","article-title":"Hepatic venous pressure gradient and prognosis in patients with acute variceal bleeding treated with pharmacologic and endoscopic therapy","volume":"48","author":"Abraldes","year":"2008","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jacr.2021.02.013_bib16","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1016\/j.jhep.2015.01.003","article-title":"Evolution in the understanding of the pathophysiological basis of portal hypertension: how changes in paradigm are leading to successful new treatments","volume":"62","author":"Bosch","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jacr.2021.02.013_bib17","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1002\/hep.28031","article-title":"The prognostic value of hepatic venous pressure gradient in patients with cirrhosis is highly dependent on the accuracy of the technique","volume":"62","author":"Silva-Junior","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jacr.2021.02.013_bib18","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1053\/j.gastro.2006.09.013","article-title":"Hepatic vein pressure gradient reduction and prevention of variceal bleeding in cirrhosis: a systematic review","volume":"131","author":"D\u2019Amico","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jacr.2021.02.013_bib19","doi-asserted-by":"crossref","first-page":"S391","DOI":"10.1016\/j.jacr.2017.08.045","article-title":"ACR Appropriateness Criteria(R) Chronic Liver Disease","volume":"14","author":"Horowitz","year":"2017","journal-title":"J\u00a0Am Coll Radiol"},{"key":"10.1016\/j.jacr.2021.02.013_bib20","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1111\/j.1365-2036.2012.05088.x","article-title":"Meta-analysis: vasoactive medications for the management of acute variceal bleeds","volume":"35","author":"Wells","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jacr.2021.02.013_bib21","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/S0140-6736(97)05099-X","article-title":"Early administration of somatostatin and efficacy of sclerotherapy in acute oesophageal variceal bleeds: the European Acute Bleeding Oesophageal Variceal Episodes (ABOVE) randomised trial","volume":"350","author":"Avgerinos","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.jacr.2021.02.013_bib22","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJM200101043440104","article-title":"Early administration of vapreotide for variceal bleeding in patients with cirrhosis","volume":"344","author":"Cales","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacr.2021.02.013_bib23","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1055\/s-0032-1301734","article-title":"Acute variceal bleeding","volume":"33","author":"Garcia-Pagan","year":"2012","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.jacr.2021.02.013_bib24","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0140-6736(95)92708-5","article-title":"Early administration of terlipressin plus glyceryl trinitrate to control active upper gastrointestinal bleeding in cirrhotic patients","volume":"346","author":"Levacher","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.jacr.2021.02.013_bib25","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1002\/hep.510300222","article-title":"Somatostatin alone or combined with emergency sclerotherapy in the treatment of acute esophageal variceal bleeding: a prospective randomized trial","volume":"30","author":"Villanueva","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.jacr.2021.02.013_bib26","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1053\/jhep.2002.31354","article-title":"Endoscopic treatment versus endoscopic plus pharmacologic treatment for acute variceal bleeding: a meta-analysis","volume":"35","author":"Banares","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.jacr.2021.02.013_bib27","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/s12072-014-9594-9","article-title":"Efficacy of vasopressin\/terlipressin and somatostatin\/octreotide for the prevention of early variceal rebleeding after the initial control of bleeding: a systematic review and meta-analysis","volume":"9","author":"Wang","year":"2015","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jacr.2021.02.013_bib28","first-page":"CD002907","article-title":"Antibiotic prophylaxis for cirrhotic patients with gastrointestinal bleeding","author":"Soares-Weiser","year":"2002","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jacr.2021.02.013_bib29","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1365-2036.2011.04746.x","article-title":"Meta-analysis: antibiotic prophylaxis for cirrhotic patients with upper gastrointestinal bleeding\u2014an updated Cochrane review","volume":"34","author":"Chavez-Tapia","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jacr.2021.02.013_bib30","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.jhep.2015.05.022","article-title":"Expanding consensus in portal hypertension: report of the Baveno VI Consensus Workshop: stratifying risk and individualizing care for portal hypertension","volume":"63","author":"de Franchis","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jacr.2021.02.013_bib31","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1136\/gut.2008.165910","article-title":"Low-dose terlipressin plus banding ligation versus low-dose terlipressin alone in the prevention of very early rebleeding of oesophageal varices","volume":"58","author":"Lo","year":"2009","journal-title":"Gut"},{"key":"10.1016\/j.jacr.2021.02.013_bib32","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1002\/hep.1840220215","article-title":"A\u00a0prospective, randomized trial of sclerotherapy versus ligation in the management of bleeding esophageal varices","volume":"22","author":"Lo","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.jacr.2021.02.013_bib33","first-page":"1769","article-title":"Prospective multicenter randomized trial comparing banding ligation with sclerotherapy of esophageal varices","volume":"46","author":"Masci","year":"1999","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.jacr.2021.02.013_bib34","first-page":"620","article-title":"Elastic band ligation for bleeding esophagogastric varices","volume":"44","author":"Van Stiegmann","year":"1997","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.jacr.2021.02.013_bib35","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1590\/S0004-28032005000200002","article-title":"Efficacy of absolute alcohol injection compared with band ligation in the eradication of esophageal varices","volume":"42","author":"Ferrari","year":"2005","journal-title":"Arq Gastroenterol"},{"key":"10.1016\/j.jacr.2021.02.013_bib36","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/MEG.0b013e3283415986","article-title":"Endoscopic treatment of esophageal varices in advanced liver disease patients: band ligation versus cyanoacrylate injection","volume":"23","author":"Santos","year":"2011","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jacr.2021.02.013_bib37","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.jhep.2006.05.016","article-title":"A\u00a0randomized controlled trial comparing ligation and sclerotherapy as emergency endoscopic treatment added to somatostatin in acute variceal bleeding","volume":"45","author":"Villanueva","year":"2006","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jacr.2021.02.013_bib38","doi-asserted-by":"crossref","first-page":"280","DOI":"10.7326\/0003-4819-123-4-199508150-00007","article-title":"Endoscopic ligation compared with sclerotherapy for treatment of esophageal variceal bleeding. A meta-analysis","volume":"123","author":"Laine","year":"1995","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacr.2021.02.013_bib39","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1007\/s10620-006-3137-8","article-title":"Improved prognosis of cirrhosis patients with esophageal varices and thrombocytopenia treated by endoscopic variceal ligation plus partial splenic embolization","volume":"51","author":"Ohmoto","year":"2006","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jacr.2021.02.013_bib40","first-page":"2849","article-title":"Endoscopic variceal ligation (EVL) combined with partial splenic embolization (PSE)","volume":"46","author":"Taniai","year":"1999","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.jacr.2021.02.013_bib41","first-page":"984","article-title":"Combined endoscopic and radiologic intervention to treat esophageal varices","volume":"49","author":"Taniai","year":"2002","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.jacr.2021.02.013_bib42","first-page":"332","article-title":"The treatment of portal hypertension: a meta-analytic review","volume":"22","author":"D\u2019Amico","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.jacr.2021.02.013_bib43","first-page":"1932","article-title":"A\u00a0comparative study of emergency transjugular intrahepatic portosystemic stent-shunt and esophageal transection in the management of uncontrolled variceal hemorrhage","volume":"90","author":"Jalan","year":"1995","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jacr.2021.02.013_bib44","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/0016-5085(86)90710-9","article-title":"Variceal bleeding: which shunt?","volume":"91","author":"Henderson","year":"1986","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jacr.2021.02.013_bib45","series-title":"Hepatology : a textbook of liver disease","author":"Zakim","year":"2003"},{"key":"10.1016\/j.jacr.2021.02.013_bib46","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.jamcollsurg.2011.12.042","article-title":"Prosthetic H-graft portacaval shunts vs transjugular intrahepatic portasystemic stent shunts: 18-year follow-up of a randomized trial","volume":"214","author":"Rosemurgy","year":"2012","journal-title":"J\u00a0Am Coll Surg"},{"key":"10.1016\/j.jacr.2021.02.013_bib47","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1053\/j.gastro.2006.02.008","article-title":"Distal splenorenal shunt versus transjugular intrahepatic portal systematic shunt for variceal bleeding: a randomized trial","volume":"130","author":"Henderson","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jacr.2021.02.013_bib48","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1177\/000313481007600831","article-title":"Surgical shunting versus transjugular intrahepatic portasystemic shunting for bleeding varices resulting from portal hypertension and cirrhosis: a meta-analysis","volume":"76","author":"Clark","year":"2010","journal-title":"Am Surg"},{"key":"10.1016\/j.jacr.2021.02.013_bib49","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1053\/gast.1996.v110.pm8608893","article-title":"Transjugular intrahepatic portosystemic shunt versus sclerotherapy in the elective treatment of variceal hemorrhage","volume":"110","author":"Cabrera","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jacr.2021.02.013_bib50","doi-asserted-by":"crossref","first-page":"858","DOI":"10.7326\/0003-4819-126-11-199706010-00002","article-title":"Endoscopic sclerotherapy compared with percutaneous transjugular intrahepatic portosystemic shunt after initial sclerotherapy in patients with acute variceal hemorrhage. A randomized, controlled trial","volume":"126","author":"Cello","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacr.2021.02.013_bib51","first-page":"1115","article-title":"A\u00a0randomized trial comparing transjugular intrahepatic portosystemic stent-shunt with variceal band ligation in the prevention of rebleeding from esophageal varices","volume":"26","author":"Jalan","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.jacr.2021.02.013_bib52","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/hep.510270109","article-title":"Transjugular intrahepatic portosystemic shunt versus endoscopic sclerotherapy for the prevention of variceal bleeding in cirrhosis: a randomized multicenter trial. Gruppo Italiano Studio TIPS (G.I.S.T.)","volume":"27","author":"Merli","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.jacr.2021.02.013_bib53","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/S0140-6736(96)08189-5","article-title":"Randomised trial of transjugular-intrahepatic-portosystemic shunt versus endoscopy plus propranolol for prevention of variceal rebleeding","volume":"349","author":"Rossle","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.jacr.2021.02.013_bib54","doi-asserted-by":"crossref","first-page":"849","DOI":"10.7326\/0003-4819-126-11-199706010-00001","article-title":"Transjugular intrahepatic portosystemic shunts compared with endoscopic sclerotherapy for the prevention of recurrent variceal hemorrhage. A randomized, controlled trial","volume":"126","author":"Sanyal","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacr.2021.02.013_bib55","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1053\/gast.1997.v113.pm9352865","article-title":"Transjugular intrahepatic portosystemic stent shunt versus sclerotherapy plus propranolol for variceal rebleeding","volume":"113","author":"Sauer","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jacr.2021.02.013_bib56","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1148\/radiology.212.2.r99au46411","article-title":"TIPS for prevention of recurrent bleeding in patients with cirrhosis: meta-analysis of randomized clinical trials","volume":"212","author":"Luca","year":"1999","journal-title":"Radiology"},{"key":"10.1016\/j.jacr.2021.02.013_bib57","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/hep.510300316","article-title":"Transjugular intrahepatic portosystemic shunt compared with endoscopic treatment for prevention of variceal rebleeding: A meta-analysis","volume":"30","author":"Papatheodoridis","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.jacr.2021.02.013_bib58","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1056\/NEJMoa0910102","article-title":"Early use of TIPS in patients with cirrhosis and variceal bleeding","volume":"362","author":"Garcia-Pagan","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacr.2021.02.013_bib59","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1002\/hep.20386","article-title":"Influence of portal hypertension and its early decompression by TIPS placement on the outcome of variceal bleeding","volume":"40","author":"Monescillo","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.jacr.2021.02.013_bib60","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1572-0241.2004.04056.x","article-title":"Polytetrafluoroethylene-covered stent grafts for TIPS procedure: 1-year patency and clinical results","volume":"99","author":"Angeloni","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jacr.2021.02.013_bib61","first-page":"1043","article-title":"Survival in patients undergoing transjugular intrahepatic portosystemic shunt: ePTFE-covered stentgrafts versus bare stents","volume":"38","author":"Angermayr","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.jacr.2021.02.013_bib62","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1111\/j.1478-3231.2007.01522.x","article-title":"Patency of stents covered with polytetrafluoroethylene in patients treated by transjugular intrahepatic portosystemic shunts: long-term results of a randomized multicentre study","volume":"27","author":"Bureau","year":"2007","journal-title":"Liver Int"},{"key":"10.1016\/j.jacr.2021.02.013_bib63","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jvir.2008.11.005","article-title":"TIPS: comparison of shunt patency and clinical outcomes between bare stents and expanded polytetrafluoroethylene stent-grafts","volume":"20","author":"Jung","year":"2009","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.jacr.2021.02.013_bib64","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1148\/radiol.2313030349","article-title":"Polytetrafluoroethylene-covered nitinol stent-graft for transjugular intrahepatic portosystemic shunt creation: 3-year experience","volume":"231","author":"Rossi","year":"2004","journal-title":"Radiology"},{"key":"10.1016\/j.jacr.2021.02.013_bib65","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1016\/j.jvir.2010.06.009","article-title":"Stent-grafts for transjugular intrahepatic portosystemic shunt creation: specialized TIPS stent-graft versus generic stent-graft\/bare stent combination","volume":"21","author":"Saad","year":"2010","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.jacr.2021.02.013_bib66","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jhep.2012.08.020","article-title":"Use of early-TIPS for high-risk variceal bleeding: results of a post-RCT surveillance study","volume":"58","author":"Garcia-Pagan","year":"2013","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jacr.2021.02.013_bib67","doi-asserted-by":"crossref","first-page":"E50","DOI":"10.1111\/tri.12090","article-title":"Salvage transjugular intrahepatic portosystemic shunt followed by early transplantation in patients with Child C14-15 cirrhosis and refractory variceal bleeding: a strategy improving survival","volume":"26","author":"Rudler","year":"2013","journal-title":"Transpl Int"},{"key":"10.1016\/j.jacr.2021.02.013_bib68","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1111\/jgh.13303","article-title":"Early TIPS versus endoscopic therapy for secondary prophylaxis after management of acute esophageal variceal bleeding in cirrhotic patients: a meta-analysis of randomized controlled trials","volume":"31","author":"Halabi","year":"2016","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.jacr.2021.02.013_bib69","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1136\/gut.48.3.390","article-title":"Transjugular intrahepatic portosystemic shunt (TIPS) versus endoscopic variceal ligation in the prevention of variceal rebleeding in patients with cirrhosis: a randomised trial","volume":"48","author":"Pomier-Layrargues","year":"2001","journal-title":"Gut"},{"key":"10.1016\/j.jacr.2021.02.013_bib70","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/01.sla.0000151884.67600.b6","article-title":"H-graft portacaval shunts versus TIPS: ten-year follow-up of a randomized trial with comparison to predicted survivals","volume":"241","author":"Rosemurgy","year":"2005","journal-title":"Ann Surg"},{"key":"10.1016\/j.jacr.2021.02.013_bib71","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1038\/ajg.2011.173","article-title":"Effectiveness of combined pharmacologic and ligation therapy in high-risk patients with acute esophageal variceal bleeding","volume":"106","author":"Augustin","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jacr.2021.02.013_bib72","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1053\/j.gastro.2013.10.018","article-title":"A\u00a0MELD-based model to determine risk of mortality among patients with acute variceal bleeding","volume":"146","author":"Reverter","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jacr.2021.02.013_bib73","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.cgh.2017.04.042","article-title":"Multicenter external validation of risk stratification criteria for patients with variceal bleeding","volume":"16","author":"Conejo","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jacr.2021.02.013_bib74","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1007\/s10620-010-1390-3","article-title":"Accuracy of MELD scores in predicting mortality in decompensated cirrhosis from variceal bleeding, hepatorenal syndrome, alcoholic hepatitis, or acute liver failure as well as mortality after non-transplant surgery or TIPS","volume":"56","author":"Al Sibae","year":"2011","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jacr.2021.02.013_bib75","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/S1665-2681(19)31278-5","article-title":"MELD score for prediction of survival after emergent TIPS for acute variceal hemorrhage: derivation and validation in a 101-patient cohort","volume":"14","author":"Casadaban","year":"2015","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.jacr.2021.02.013_bib76","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jvir.2012.10.026","article-title":"Prognostic capability of different liver disease scoring systems for prediction of early mortality after transjugular intrahepatic portosystemic shunt creation","volume":"24","author":"Gaba","year":"2013","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.jacr.2021.02.013_bib77","first-page":"5211","article-title":"Clinical outcome and predictors of survival after TIPS insertion in patients with liver cirrhosis","volume":"18","author":"Heinzow","year":"2012","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jacr.2021.02.013_bib78","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s00270-004-0145-y","article-title":"MELD score as a predictor of early death in patients undergoing elective transjugular intrahepatic portosystemic shunt (TIPS) procedures","volume":"28","author":"Montgomery","year":"2005","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.jacr.2021.02.013_bib79","doi-asserted-by":"crossref","first-page":"481","DOI":"10.3348\/kjr.2009.10.5.481","article-title":"Prediction of mortality after\u00a0emergent transjugular intrahepatic portosystemic shunt placement: use of APACHE II, Child-Pugh and MELD scores in Asian patients with refractory variceal hemorrhage","volume":"10","author":"Tzeng","year":"2009","journal-title":"Korean J Radiol"},{"key":"10.1016\/j.jacr.2021.02.013_bib80","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1159\/000335081","article-title":"Acute management of refractory variceal bleeding in liver cirrhosis by self-expanding metal stents","volume":"85","author":"Dechene","year":"2012","journal-title":"Digestion"},{"key":"10.1016\/j.jacr.2021.02.013_bib81","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1159\/000350192","article-title":"Treatment of esophageal variceal hemorrhage with self-expanding metal stents as a rescue maneuver in a swiss multicentric cohort","volume":"7","author":"Fierz","year":"2013","journal-title":"Case Rep Gastroenterol"},{"key":"10.1016\/j.jacr.2021.02.013_bib82","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.gie.2009.07.028","article-title":"A\u00a0self-expanding metal stent for complicated variceal hemorrhage: experience at a single center","volume":"71","author":"Wright","year":"2010","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.jacr.2021.02.013_bib83","doi-asserted-by":"crossref","first-page":"177","DOI":"10.4103\/1319-3767.114516","article-title":"The first Egyptian experience using new self-expandable metal stents in acute esophageal variceal bleeding: pilot study","volume":"19","author":"Zakaria","year":"2013","journal-title":"Saudi J Gastroenterol"},{"key":"10.1016\/j.jacr.2021.02.013_bib84","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1007\/s00464-008-0009-7","article-title":"Results of a new method to stop acute bleeding from esophageal varices: implantation of a self-expanding stent","volume":"22","author":"Zehetner","year":"2008","journal-title":"Surg Endosc"},{"key":"10.1016\/j.jacr.2021.02.013_bib85","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1097\/MEG.0000000000001222","article-title":"Model for end-stage liver disease score and hemodynamic instability as a predictor of poor outcome in early transjugular intrahepatic portosystemic shunt treatment for acute variceal hemorrhage","volume":"30","author":"Hermie","year":"2018","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jacr.2021.02.013_bib86","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1053\/jhep.2003.50385","article-title":"Upper digestive bleeding in cirrhosis. Post-therapeutic outcome and prognostic indicators","volume":"38","author":"D\u2019Amico","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.jacr.2021.02.013_bib87","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/lt.21941","article-title":"Portal vein thrombosis and survival in patients with cirrhosis","volume":"16","author":"Englesbe","year":"2010","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jacr.2021.02.013_bib88","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/hep.1840220147","article-title":"Transjugular intrahepatic portosystemic shunt for refractory ascites: tipping the sodium balance","volume":"22","author":"Wong","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.jacr.2021.02.013_bib89","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s00270-002-1912-2","article-title":"Transjugular intrahepatic portosystemic shunt (TIPS): current status and future possibilities","volume":"25","author":"Bilbao","year":"2002","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.jacr.2021.02.013_bib90","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0732-8893(99)00021-8","article-title":"Detection of ileS-2 gene encoding mupirocin resistance in methicillin-resistant Staphylococcus aureus by multiplex PCR","volume":"34","author":"Nunes","year":"1999","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.jacr.2021.02.013_bib91","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1159\/000084726","article-title":"Transjugular intrahepatic portosystemic shunt","volume":"23","author":"Ochs","year":"2005","journal-title":"Dig Dis"},{"key":"10.1016\/j.jacr.2021.02.013_bib92","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1111\/j.1572-0241.2006.00763_3.x","article-title":"Transjugular intrahepatic portosystemic shunt (TIPS), the preferred therapeutic option for Budd Chiari syndrome associated with portal vein thrombosis","volume":"101","author":"Senzolo","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jacr.2021.02.013_bib93","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/j.1365-2036.2006.02820.x","article-title":"Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with and without cavernous transformation","volume":"23","author":"Senzolo","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jacr.2021.02.013_bib94","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1097\/MEG.0000000000001219","article-title":"The role of transjugular intrahepatic portosystemic shunt in the management of portal vein thrombosis: a systematic review and meta-analysis","volume":"30","author":"Valentin","year":"2018","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jacr.2021.02.013_bib95","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1177\/028418517401500509","article-title":"Sclerosing injection of esophageal varices through transhepatic selective catheterization of the gastric coronary vein. A preliminary report","volume":"15","author":"Lunderquist","year":"1974","journal-title":"Acta Radiol Diagn (Stockh)"},{"key":"10.1016\/j.jacr.2021.02.013_bib96","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1007\/s12072-013-9433-4","article-title":"Percutaneous transhepatic variceal embolization with cyanoacrylate vs. transjugular intrahepatic portal systematic shunt for esophageal variceal bleeding","volume":"7","author":"Tian","year":"2013","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jacr.2021.02.013_bib97","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1007\/s00270-011-0311-y","article-title":"Percutaneous transsplenic access to the portal vein for management of vascular complication in patients with chronic liver disease","volume":"35","author":"Chu","year":"2012","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.jacr.2021.02.013_bib98","doi-asserted-by":"crossref","first-page":"880","DOI":"10.3748\/wjg.v7.i6.880","article-title":"Percutaneous transsplenic embolization of esophageal and gastrio-fundal varices in 18 patients","volume":"7","author":"Gong","year":"2001","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jacr.2021.02.013_bib99","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1016\/j.jvir.2007.08.009","article-title":"Percutaneous transsplenic access in the management of bleeding varices from chronic portal vein thrombosis","volume":"18","author":"Tuite","year":"2007","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.jacr.2021.02.013_bib100","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1007\/s10620-005-2787-2","article-title":"Chronic albumin infusions to achieve diuresis in patients with ascites who are not candidates for transjugular intrahepatic portosystemic shunt (TIPS)","volume":"50","author":"Trotter","year":"2005","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jacr.2021.02.013_bib101","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1440-1746.2011.06925.x","article-title":"Management of ascites in cirrhosis","volume":"27","author":"Wong","year":"2012","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.jacr.2021.02.013_bib102","doi-asserted-by":"crossref","first-page":"125","DOI":"10.2174\/157016111201140327163930","article-title":"Pathophysiology, diagnosis and clinical management of hepatorenal syndrome: from classic to new drugs","volume":"12","author":"Barbano","year":"2014","journal-title":"Curr Vasc Pharmacol"},{"key":"10.1016\/j.jacr.2021.02.013_bib103","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/hep.20829","article-title":"A\u00a0randomized unblinded pilot study comparing albumin versus hydroxyethyl starch in spontaneous bacterial peritonitis","volume":"42","author":"Fernandez","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jacr.2021.02.013_bib104","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1517\/14656566.2011.561200","article-title":"Hepatorenal syndrome","volume":"12","author":"Guevara","year":"2011","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.jacr.2021.02.013_bib105","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0168-8278(99)80194-9","article-title":"Albumin improves the response to diuretics in patients with cirrhosis and ascites: results of a randomized, controlled trial","volume":"30","author":"Gentilini","year":"1999","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jacr.2021.02.013_bib106","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.3748\/wjg.v12.i9.1403","article-title":"Long-term albumin infusion improves survival in patients with cirrhosis and ascites: an unblinded randomized trial","volume":"12","author":"Romanelli","year":"2006","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jacr.2021.02.013_bib107","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1136\/gutjnl-2011-300157","article-title":"Satavaptan for the management of ascites in cirrhosis: efficacy and safety across the spectrum of ascites severity","volume":"61","author":"Wong","year":"2012","journal-title":"Gut"},{"key":"10.1016\/j.jacr.2021.02.013_bib108","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/hep.22293","article-title":"Effects of satavaptan, a selective vasopressin V(2) receptor antagonist, on ascites and serum sodium in cirrhosis with hyponatremia: a randomized trial","volume":"48","author":"Gines","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jacr.2021.02.013_bib109","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1111\/j.1365-2036.2010.04236.x","article-title":"Clinical trial: short-term effects of combination of satavaptan, a selective vasopressin V2 receptor antagonist, and diuretics on ascites in patients with cirrhosis without hyponatraemia\u2014a randomized, double-blind, placebo-controlled study","volume":"31","author":"Gines","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jacr.2021.02.013_bib110","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.jhep.2010.02.036","article-title":"Effects of a selective vasopressin V2 receptor antagonist, satavaptan, on ascites recurrence after paracentesis in patients with cirrhosis","volume":"53","author":"Wong","year":"2010","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jacr.2021.02.013_bib111","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/hep.23775","article-title":"Deleterious effects of beta-blockers on survival in patients with cirrhosis and refractory ascites","volume":"52","author":"Serste","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jacr.2021.02.013_bib112","first-page":"164","article-title":"Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club","volume":"23","author":"Arroyo","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.jacr.2021.02.013_bib113","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1056\/NEJM199109193251201","article-title":"Paracentesis with intravenous infusion of albumin as compared with peritoneovenous shunting in cirrhosis with refractory ascites","volume":"325","author":"Gines","year":"1991","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacr.2021.02.013_bib114","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1053\/jhep.2003.50315","article-title":"The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club","volume":"38","author":"Moore","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.jacr.2021.02.013_bib115","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1002\/hep.22853","article-title":"Management of adult patients with ascites due to cirrhosis: an update","volume":"49","author":"Runyon","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jacr.2021.02.013_bib116","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.3748\/wjg.v20.i10.2704","article-title":"TIPS improves liver transplantation-free survival in cirrhotic patients with refractory ascites: an updated meta-analysis","volume":"20","author":"Bai","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jacr.2021.02.013_bib117","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/0016-5085(87)91007-9","article-title":"Comparison of paracentesis and diuretics in the treatment of cirrhotics with tense ascites. Results of a randomized study","volume":"93","author":"Gines","year":"1987","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jacr.2021.02.013_bib118","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S0168-8278(87)80067-3","article-title":"Repeated paracentesis and i.v. albumin infusion to treat \u201ctense\u201d ascites in cirrhotic patients. A safe alternative therapy","volume":"5","author":"Salerno","year":"1987","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jacr.2021.02.013_bib119","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/0016-5085(88)90691-9","article-title":"Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis","volume":"94","author":"Gines","year":"1988","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jacr.2021.02.013_bib120","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/0016-5085(94)90706-4","article-title":"Time course of circulatory and humoral effects of rapid total paracentesis in cirrhotic patients with tense, refractory ascites","volume":"106","author":"Pozzi","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jacr.2021.02.013_bib121","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1053\/gast.1997.v113.pm9247479","article-title":"Paracentesis-induced circulatory dysfunction: mechanism and effect on hepatic hemodynamics in cirrhosis","volume":"113","author":"Ruiz-del-Arbol","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jacr.2021.02.013_bib122","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1111\/j.1478-3231.2008.01734.x","article-title":"Prevention of paracentesis-induced circulatory dysfunction: midodrine vs albumin. A randomized pilot study","volume":"28","author":"Appenrodt","year":"2008","journal-title":"Liver Int"},{"key":"10.1016\/j.jacr.2021.02.013_bib123","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/S0016-5085(96)70068-9","article-title":"Randomized trial comparing albumin, dextran 70, and polygeline in cirrhotic patients with ascites treated by paracentesis","volume":"111","author":"Gines","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jacr.2021.02.013_bib124","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/0016-5085(90)90481-F","article-title":"Dextran-70 versus albumin as plasma expanders in cirrhotic patients with tense ascites treated with total paracentesis. Results of a randomized study","volume":"99","author":"Planas","year":"1990","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jacr.2021.02.013_bib125","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1053\/jhep.2003.50169","article-title":"Randomized trial comparing albumin and saline in the prevention of paracentesis-induced circulatory dysfunction in cirrhotic patients with ascites","volume":"37","author":"Sola-Vera","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.jacr.2021.02.013_bib126","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1478-3231.2005.01188.x","article-title":"Comparison of outcome in patients with cirrhosis and ascites following treatment with albumin or a synthetic colloid: a randomised controlled pilot trail","volume":"26","author":"Moreau","year":"2006","journal-title":"Liver Int"},{"key":"10.1016\/j.jacr.2021.02.013_bib127","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1111\/j.1478-3231.2010.02272.x","article-title":"Refractory ascites: pathogenesis, definition and therapy of a severe complication in patients with cirrhosis","volume":"30","author":"Salerno","year":"2010","journal-title":"Liver Int"},{"key":"10.1016\/j.jacr.2021.02.013_bib128","first-page":"1930","article-title":"The efficacy of terlipressin in comparison with albumin in the prevention of circulatory changes after the paracentesis of tense ascites\u2014a randomized multicentric study","volume":"54","author":"Lata","year":"2007","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.jacr.2021.02.013_bib129","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1136\/gut.50.1.90","article-title":"Comparison of the effect of terlipressin and albumin on arterial blood volume in patients with cirrhosis and tense ascites treated by paracentesis: a randomised pilot study","volume":"50","author":"Moreau","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.jacr.2021.02.013_bib130","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1440-1746.2006.04182.x","article-title":"Terlipressin versus albumin in paracentesis-induced circulatory dysfunction in cirrhosis: a randomized study","volume":"21","author":"Singh","year":"2006","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.jacr.2021.02.013_bib131","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1111\/j.1572-0241.2008.01787.x","article-title":"Midodrine versus albumin in the prevention of paracentesis-induced circulatory dysfunction in cirrhotics: a randomized pilot study","volume":"103","author":"Singh","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jacr.2021.02.013_bib132","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0168-8278(96)80065-1","article-title":"Transjugular intrahepatic portosystemic shunts: comparison with paracentesis in patients with cirrhosis and refractory ascites: a randomized trial. French Group of Clinicians and a Group of Biologists","volume":"25","author":"Lebrec","year":"1996","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jacr.2021.02.013_bib133","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1056\/NEJM200006083422303","article-title":"A\u00a0comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites","volume":"342","author":"Rossle","year":"2000","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacr.2021.02.013_bib134","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1053\/gast.2003.50088","article-title":"The North American Study for the Treatment of Refractory Ascites","volume":"124","author":"Sanyal","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jacr.2021.02.013_bib135","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1053\/gast.2002.37073","article-title":"Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis","volume":"123","author":"Gines","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jacr.2021.02.013_bib136","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s00535-010-0282-9","article-title":"Transjugular intrahepatic portosystemic shunt versus paracentesis plus albumin in patients with refractory ascites who have good hepatic and renal function: a prospective randomized trial","volume":"46","author":"Narahara","year":"2011","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1016\/j.jacr.2021.02.013_bib137","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/hep.20364","article-title":"Randomized controlled study of TIPS versus paracentesis plus albumin in cirrhosis with severe ascites","volume":"40","author":"Salerno","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.jacr.2021.02.013_bib138","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1097\/00000658-197410000-00023","article-title":"Peritoneo-venous shunting for ascites","volume":"180","author":"Leveen","year":"1974","journal-title":"Ann Surg"},{"key":"10.1016\/j.jacr.2021.02.013_bib139","doi-asserted-by":"crossref","first-page":"W449","DOI":"10.2214\/AJR.12.9203","article-title":"Percutaneous placement and management of the Denver shunt for portal hypertensive ascites","volume":"199","author":"Martin","year":"2012","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.jacr.2021.02.013_bib140","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s00270-006-0213-6","article-title":"Radiological insertion and management of peritoneovenous shunt","volume":"30","author":"Bratby","year":"2007","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.jacr.2021.02.013_bib141","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1016\/j.athoracsur.2005.06.021","article-title":"Massive pneumoperitoneum: a late complication of the Denver pleuroperitoneal shunt","volume":"80","author":"Foroulis","year":"2005","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jacr.2021.02.013_bib142","first-page":"228","article-title":"Pneumoperitoneum and signs of peritonitis from a pleuroperitoneal shunt","volume":"111","author":"Lopez-Viego","year":"1992","journal-title":"Surgery"},{"key":"10.1016\/j.jacr.2021.02.013_bib143","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1097\/01.sla.0000128309.36393.71","article-title":"TIPS versus peritoneovenous shunt in the treatment of medically intractable ascites: a prospective randomized trial","volume":"239","author":"Rosemurgy","year":"2004","journal-title":"Ann Surg"},{"key":"10.1016\/j.jacr.2021.02.013_bib144","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S0002-9610(01)00565-7","article-title":"Management of medically refractory ascites","volume":"181","author":"Zervos","year":"2001","journal-title":"Am J Surg"},{"key":"10.1016\/j.jacr.2021.02.013_bib145","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1053\/j.gastro.2016.02.026","article-title":"Terlipressin plus albumin is more effective than albumin alone in improving renal function in patients with cirrhosis and hepatorenal syndrome type 1","volume":"150","author":"Boyer","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jacr.2021.02.013_bib146","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/apt.13912","article-title":"Systematic review with meta-analysis: vasoactive drugs for the treatment of hepatorenal syndrome type 1","volume":"45","author":"Gifford","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jacr.2021.02.013_bib147","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.semnephrol.2018.10.002","article-title":"Epidemiology, pathophysiology, and management of hepatorenal syndrome","volume":"39","author":"Amin","year":"2019","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.jacr.2021.02.013_bib148","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.jhep.2010.05.004","article-title":"EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis","volume":"53","year":"2010","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jacr.2021.02.013_bib149","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1002\/hep.26359","article-title":"Introduction to the revised American Association for the Study of Liver Diseases Practice Guideline management of adult patients with ascites due to cirrhosis 2012","volume":"57","author":"Runyon","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jacr.2021.02.013_bib150","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1080\/17474124.2018.1417034","article-title":"Hepatorenal syndrome: the clinical impact of vasoactive therapy","volume":"12","author":"Colle","year":"2018","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jacr.2021.02.013_bib151","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/hep.27709","article-title":"Terlipressin plus albumin versus midodrine and octreotide plus albumin in the treatment of hepatorenal syndrome: a randomized trial","volume":"62","author":"Cavallin","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jacr.2021.02.013_bib152","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1111\/j.1572-0241.2008.01828.x","article-title":"An open label, pilot, randomized controlled trial of noradrenaline versus terlipressin in the treatment of type 1 hepatorenal syndrome and predictors of response","volume":"103","author":"Sharma","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jacr.2021.02.013_bib153","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1111\/liv.12179","article-title":"Noradrenaline vs terlipressin in the treatment of type 2 hepatorenal syndrome: a randomized pilot study","volume":"33","author":"Ghosh","year":"2013","journal-title":"Liver Int"},{"key":"10.1016\/j.jacr.2021.02.013_bib154","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1111\/apt.14052","article-title":"Reversal of hepatorenal syndrome type 1 with terlipressin plus albumin vs. placebo plus albumin in a pooled analysis of the OT-0401 and REVERSE randomised clinical studies","volume":"45","author":"Sanyal","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jacr.2021.02.013_bib155","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jhep.2010.11.020","article-title":"Predictors of response to terlipressin plus albumin in hepatorenal syndrome (HRS) type 1: relationship of serum creatinine to hemodynamics","volume":"55","author":"Boyer","year":"2011","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jacr.2021.02.013_bib156","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1053\/j.gastro.2008.02.014","article-title":"A\u00a0randomized, prospective, double-blind, placebo-controlled trial of terlipressin for type 1 hepatorenal syndrome","volume":"134","author":"Sanyal","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jacr.2021.02.013_bib157","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1007\/s10620-007-9919-9","article-title":"Terlipressin and albumin in patients with cirrhosis and type I hepatorenal syndrome","volume":"53","author":"Neri","year":"2008","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jacr.2021.02.013_bib158","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1046\/j.1440-1746.2003.02934.x","article-title":"Beneficial effects of terlipressin in hepatorenal syndrome: a prospective, randomized placebo-controlled clinical trial","volume":"18","author":"Solanki","year":"2003","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.jacr.2021.02.013_bib159","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s11606-017-4178-8","article-title":"Vasoactive agents for hepatorenal syndrome: a mixed treatment comparison network meta-analysis and trial sequential analysis of randomized clinical trials","volume":"33","author":"Sridharan","year":"2018","journal-title":"J\u00a0Gen Intern Med"},{"key":"10.1016\/j.jacr.2021.02.013_bib160","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s12876-015-0389-9","article-title":"Albumin treatment regimen for type 1 hepatorenal syndrome: a dose-response meta-analysis","volume":"15","author":"Salerno","year":"2015","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.jacr.2021.02.013_bib161","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1136\/gut.47.2.288","article-title":"Long term outcome after transjugular intrahepatic portosystemic stent-shunt in non-transplant cirrhotics with hepatorenal syndrome: a phase II study","volume":"47","author":"Brensing","year":"2000","journal-title":"Gut"},{"key":"10.1016\/j.jacr.2021.02.013_bib162","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/hep.510280219","article-title":"Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome: effects on renal function and vasoactive systems","volume":"28","author":"Guevara","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.jacr.2021.02.013_bib163","first-page":"1766","article-title":"Transjugular intrahepatic portacaval stent shunts in patients with renal insufficiency","volume":"25","author":"Lake","year":"1993","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jacr.2021.02.013_bib164","first-page":"1753","article-title":"Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation","volume":"50","author":"Testino","year":"2003","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.jacr.2021.02.013_bib165","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/hep.20262","article-title":"Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome","volume":"40","author":"Wong","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.jacr.2021.02.013_bib166","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/ki.1986.249","article-title":"Peritoneovenous shunt in the management of the hepatorenal syndrome","volume":"30","author":"Linas","year":"1986","journal-title":"Kidney Int"}],"container-title":["Journal of the American College of Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1546144021001460?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1546144021001460?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T06:25:55Z","timestamp":1761546355000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1546144021001460"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":166,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S1546144021001460"],"URL":"https:\/\/doi.org\/10.1016\/j.jacr.2021.02.013","relation":{},"ISSN":["1546-1440"],"issn-type":[{"value":"1546-1440","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ACR Appropriateness Criteria\u00ae Radiologic Management of Portal Hypertension","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacr.2021.02.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 American College of Radiology","name":"copyright","label":"Copyright"}]}}